Comparison in US Adolescents of the Safety and Immunogenicity of Two Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccines: ADACEL and BOOSTRIX
Phase of Trial: Phase IV
Latest Information Update: 04 Oct 2012
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Sanofi
- 02 Feb 2010 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 02 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Apr 2008 The expected completion date for this trial is now 1 Oct 2008 according to ClinicalTrials.gov.